Displaying 1 - 1 of 1
| Active Ingredient | CEFTAZIDIME |
| Therapeutic Class | THIRD GEN CEPHALOSPORINS |
| Indications | Infections caused by susceptible Gram-positive and Gram-negative bacteria, especially infections due to Pseudomonas spp . |
| Caution | Transient increases in transaminases, eosinophilia, diarrhea, immune hypersensitivity reaction, phlebitis, rash (maculopapular or erythematous), thrombocytosis, injection site pain, abdominal pain |
| Dose Range | Adult:1g every 8-12 hours. Maximum 6g daily . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding | Present in milk in low concentration, but appropriate to use. |